Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer's disease

Background Alzheimer's disease (AD) is a complex disease that shares clinical features with other dementias. It is important to establish a specific and reliable diagnosis. Nowadays, AD diagnosis is based on cerebrospinal fluid (CSF) biomarkers. However, the corresponding cut‐offs differ amongs...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical investigation 2023-03, Vol.53 (3), p.e13910-n/a
Hauptverfasser:	Peña‐Bautista, Carmen, Álvarez‐Sánchez, Lourdes, Pascual, Rosa, Moreno, Maria José, Baquero, Miguel, Cháfer‐Pericás, Consuelo
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer disease Alzheimer Disease - diagnosis Alzheimer's disease Amyloid beta-Peptides Biomarkers Biomarkers - cerebrospinal fluid Cerebrospinal fluid Dementia Dementia disorders Diagnosis Differential diagnosis Evaluation Frontotemporal Dementia Humans Neurodegenerative diseases Neurology Peptide Fragments Tau protein tau Proteins - cerebrospinal fluid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!